Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Aggressive Hybrid Fund median (30 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 02 Jan 2013 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 50 history starts 18 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Canara Robeco Equity Hybrid Fund |
|---|---|
| 02 Jan 2013 | ₹100.00 |
| 21 Feb 2014 | ₹100.17 |
| 12 Apr 2015 | ₹162.39 |
| 31 May 2016 | ₹158.13 |
| 19 Jul 2017 | ₹199.96 |
| 07 Sep 2018 | ₹224.72 |
| 27 Oct 2019 | ₹239.90 |
| 15 Dec 2020 | ₹292.12 |
| 03 Feb 2022 | ₹373.83 |
| 25 Mar 2023 | ₹366.50 |
| 12 May 2024 | ₹483.12 |
| 01 Jul 2025 | ₹572.17 |
| 20 Aug 2026 | ₹592.40 |
| Metric | Canara Robeco · Direct NAV ₹427.00 High risk ★★★★☆ | Category median Aggressive Hybrid Fund · 30 funds |
|---|---|---|
| +4.22% | +4.10% | |
| +12.70% | +12.70% | |
| +10.90% | +11.11% | |
| +13.12% | +12.19% | |
| +13.94% | +12.98% | |
| +11.00% | — | |
| +14.68% | +14.27% | |
| +14.53% | +14.04% | |
| +14.55% | +13.80% | |
| Risk | ||
| 10.59% | 10.62% | |
| 0.58 | 0.58 | |
| 0.80 | 0.80 | |
| -25.69% | -28.65% | |
| Nifty 50 | — | |
| +4.09% | +4.10% | |
| 0.80 | 0.80 | |
| 93.2% | 92.5% | |
| 61.8% | 60.5% | |
| 0.65% | 1.00% | |
| ₹10,986Cr | ₹2,217Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹1.00K | — | |
| ₹5.00K | — | |
| 37% | 37% | |
| Shridatta Bhandwaldar | — | |
| 02 Jan 2013 | — | |
| 72 | — | |
| 29.6% | — | |
| 5.0% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.